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A B S T R A C T
Acute Zika virus infection [87_TD$DIFF]usually presents with a self-limiting triad of fever, rash and arthritis. There is
limited information on severe or lethal cases. We report three cases of lethal acute Zika infection,
conﬁrmed with polymerase chain reaction, in adult patients with some co-morbidities. The patients
showed rapid clinical deteriorationwith hemorrhagic and septic shock, and exaggerated acute and innate
inﬂammatory responses with pronounced coagulopathy, and died soon after admission to the hospital. It
remains unclear whether the fatal outcomes were due to acute Zika virus infection alone or to the
combination with exacerbated underlying prior disease or co-infection. Nonetheless, the severity of
these cases implies that increased awareness for atypical presentations of Zika virus infection, and careful
clinical assessment of patients with symptoms of Zika, is warranted during current and future outbreaks.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Zika virus (ZIKV) is a vector-borne virus (family Flaviviridae,
genus Flavivirus) transmitted by Aedes mosquitos [1]. In 2015 the
virus rapidly caused an epidemic in many South and Central
American and Caribbean countries [2]. Two geographically distinct
lineages (i.e., the African and Asian lineage) of ZIKV exist [1]. The
ZIKV strain in Suriname resembles the Asian lineage and the ﬁrst
clinical cases appeared around September 2015 [3].
ZIKV infection usually presents with a mild self-limiting triad
of fever, maculopapular rash, and polyarthralgia, sometimes
accompanied by bilateral conjunctivitis [1,2]. ZIKV infection has
been associated with congenital brain malformations and
microcephaly among newborns and neurological complications
(e.g., Guillain-Barre syndrome) in adults .[4,5] The exact impact of
these complications is now under further investigation, but may
indicate increased virulent potential of ZIKV in the Americas.
Lethal potential of acute ZIKV infection in adults has been
described in a recent report from Colombia [6]. In these cases,
underlying prior disease may have contributed to the lethal
outcome and host-responses such as severe thrombocytopenia
and septic shock were consistently observed. A conﬁrmed severe
non-lethal case from Suriname also presented with thrombocy-
topenia and subcutaneous bleeding [7]. Additionally, a case of
lethal ZIKV infection in an adolescent girl with sickle cell anemia
suggests an association of a fatal outcome with aberrant vascular
responses leading to exacerbation of vaso-occlusive events [8].
Here, we provide a detailed clinical and diagnostic report of
three adults presenting with septic shock and multi-organ failure
in which ZIKV was the only identiﬁed pathogen. With our report
we intend to emphasize the need for increased awareness of
atypical and severe presentations of acute ZIKV infection during
the current and future outbreaks.
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Methods
Real-time PCR
For all RT-PCR analyses, viral RNAwas extracted manually from
150mL of an EDTA-plasma specimen by using the E.Z.N.A. Viral
RNA Kit (OMEGA Bio-Tek, Norcross, GA, USA), according to the
manufacturer’s instructions. CHIKV RT-PCR was performed
according to Pastorino et al. with a CHIKV speciﬁc primer set
targeting a region of the envelope-protein 1 gene of CHIKV
(F-CHIK: 50-AAGCTYCGC GTCCTTTACCAAAG-30 and R-CHIK: 50-
CCAAATTGTCCYGGTCTTCCT-30).[9] DENV PCR was performed
according to Lanciotti et al. with a primer set speciﬁc for the
DENV-envelope gene (DEN-F: 50-TTAGAGG AGACCCCTCCC-30 DEN-
R: 50-TCTCCTCTAACCTCTAGTCC-30).[10] For ZIKV PCR, a ZIKV-
positive control was obtained from the Arboviral Diseases Branch
of the Center for Disease Control and Prevention (Fort Collins,
Colorado, USA). RT-PCR for ZIKV was performed according to the
protocol of Lanciotti et al., with the following modiﬁcation: SYBR
Green I Dye (Thermo Scientiﬁc)was used for detection [11]. For this
method, high sensitivity was already shown in studies for
detection of dengue and chikungunya viruses [12]. A set of ZIKV
speciﬁc primers were used: ZIKV 835: 50 TTGGTCATGATACTGCT-
GATTGC-30; ZIKV 911c 50CCTTCCACAAAGTCCCTATTGC-30; ZIKV
1086: 50 CCGCTGCCCAAC ACAAG-30; ZIKV 1162c: 50 CCAC-
TAACGTTCTTTTGCAGACAT-30. Ampliﬁcation of viral RNA was
performed with a LightCycler 480 (LC480) Real-Time PCR system
(Roche) and viral load (Fig. 1B) was determined with
LC480 software. Nucleotide sequence of the ZIKV envelope was
obtained and a phylogenetic tree was constructed with CLC Main
Workbench 6 Software by neighbor joining of ZIKV envelope gene
sequences of earlier Surinam cases to trace the origin of the ZIKV
isolate of our ﬁrst case (Fig. 1C, branch 21068, 2015, Suriname) [3].
For Case 2 a 22 multiplex PCR (Pathoﬁnder BV, Maastricht, The
Netherlands) for viral and bacterial pathogens was performed on
an oro-pharyngeal swab kept in universal transport medium
(Copan diagnostics, Italy).
Serologic testing
Serology for chikungunya was performed with an Anti-CHIKV
IgM and IgG ELISA (EuroImmun, Lubeck, Germany) and for dengue
with the RapidSignal IgG/IgM quicktest (Orgenics, Yavne, Israel),
both according to the manufacturers’ instructions. Presence of
acute or prior HIV infection was performed with the Architect HIV
antigen/antibody assay (Abbott). Leptospirosis IgM detection was
performed with and Leptocheck (Zephyr Biomedicals, Verna,
India).
Ethics statement
We received approval from our institutional ethics committee




A 61-year-old Surinamese male with known history of
hypertension, treated with atenolol, presented at the emergency
room (ER) with a 2-day history of vomiting, watery diarrhea, and
arthritis (Fig. 1A). Physical examination revealed tachypnea with
hypoxia, tachycardiawith hypotension and acrocyanosis of the left
upper extremity. During examination the patient appeared
unresponsive. Bedside glucose level was low and rapidly corrected
[(Fig._1)TD$FIG]
Fig. 1. A. Schematic representation of history and course of disease for all described cases. B. RT-PCR ampliﬁcation result for ZIKV performed in patient serum of Case 1. C.
Phylogenetic analysis of Case 1 constructed from nucleic-acid sequence data from former Surinamese cases by neighbor-joining algorithm.
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with intravenous administration of glucose. Laboratory results on
admission showed severe leukocytosis with neutrophilia, high
C-reactive protein (CRP), severe metabolic acidosis, severe renal
failurewith electrolyte disorders, elevated liver panel, and elevated
lactate dehydrogenase (LDH) (Table 1). Ciproﬂoxacin treatment
was started after culture samples were taken.
The patient was admitted to the ICU where his condition
deteriorated requiring mechanical ventilation. Severe hemody-
namic instability urged treatment with high-dose inotropics and
large volumes of intravenous ﬂuids. The patient developed
hypothermia,multiple organ failure, and persisting lactate acidosis
despite bicarbonate infusion and steroids. Anuric renal failure
urged continuous veno-venous hemoﬁltration. Over the course of
admission the patient exhibited clinical coagulation disorders by
elongated prothrombin time (PT) and activated partial thrombo-
plastin time (APTT) with mucosal bleeding, petechiae and
ecchymosis and was treated with fresh frozen plasma (FFP) and
vitamin K. Creatinine kinase (CK) and creatinine kinase-MB
(CK-MB) were elevated (Table 1). Electrocardiography (ECG)
showed no sign of myocardial infarction. Thirty-one hour after
admission the patient died due to irreversible bradycardia
followed by cardiac arrest. Bacterial cultures from blood, sputum,
urine and stool were negative. Leptospirosis IgM and HIV serology
were negative. Serology was negative for dengue IgM and IgG, but
weakly positive for chikungunya IgM. Speciﬁc reverse transcrip-
tion real-time polymerase chain reaction (RT-PCR) was negative
for dengue and chikungunya, but positive for ZIKV. Viral load was
high with 1109 copies/mL (Fig. 1B).
Case 2
A 64-year-old male from the Netherlands with a history of type
2 diabetes mellitus (DM), treated with metformin, and epilepsy,
treated with carbamazepine, presented at ER with a 4-day history
of fever, productive cough, vomiting and diarrhea (Fig. 1A). He also
complained of overall weakness and had collapsed twice prior to
presentation. Physical examination revealed obesity, fever and
tachypnea, irregular heart rhythm, but normal blood pressure.
Initial laboratory results showed leukocytosis, thrombocytopenia
and elevated CRP, creatinine, blood glucose, and CK levels (Table 1).
He was admitted to the ward, where empiric antimicrobial
treatment with amoxicillin/clavulanic acid and gentamicin for
suspected community-acquired pneumonia or sepsis was started
after blood cultures were taken. Within twelve hours, the patient
developed respiratory and circulatory failure, and neurological
deterioration. He was intubated and transferred to the ICU for
mechanical ventilation and hemodynamic support with ﬂuids and
inotropics. Laboratory results showed coagulopathy (Table 1).
His condition seemed to stabilize for one day, but then quickly
deteriorated further intowhatwas interpreted as septic shockwith
progressive multi-organ failure, anasarca, petechiae and ecchy-
mosis, despite high-dose inotropics, prednisone, and switch of
antimicrobials to meropenem. CK and CK-MB levels increased
(Table 1), yet there were no signs of myocardial infarction on ECG.
Repeated chest X-rays showed no pulmonary inﬁltration. CT scan
of the brain and abdominal ultrasound were normal. He remained
dependent onmechanical ventilation and circulatory support with
high-dose inotropics. After three days in the ICU, the patient died.
Serology for leptospirosis IgM and HIV was negative. Spinal ﬂuid
analysis showed no evidence for (meningococcal) meningitis and
bacterial cultures from blood, sputum, urine, stool and cerebro-
spinal ﬂuid were negative. Multiplex PCR for respiratory microbial
pathogens, including Inﬂuenza A (including H1N1) and B, was
negative. Serology and RT-PCR were negative for dengue and
chikungunya, but RT-PCR was positive for ZIKV, with a viral load of
8400 copies/mL.
Case 3
A 59-year-old Surinamese male with prior history of chronic
obstructive pulmonary disease presented with a 5-day history of
fever and chills, generalized arthralgia, nausea, vomiting, and
diarrhea (Fig. 1A). Physical examination revealed fever, tachycar-
dia, hypotension, and signs of dehydration. Intravenous ﬂuids
Table 1
Results of laboratory testing on admission and microbiological analysis.
Case 1 Case 2 Case 3 Reference Values
Hemoglobin (mmol/L) 8.2 10.1 8.4 8.7–11.2
Hematocrit (L/L) 0.36 0.45 0.36 0.37–0.47
White blood cell count
(% polymorphonuclear) (x109/L)
39.8 (75.8) 19.2 (88.5)[1] 16.0 (85.7) 4.5–11.0
Platelets (x109/L) 108 154 52 130–400
C-reactive protein (mg/dL) 26.3 39.1 37.8 0–0.5
Glucose (mg/dL) 37.8 281.1 129.7 72.1–117.1
Creatinine (mg/dL) 7.2 1.6 2.4 0.7–1.2
Blood urea nitrogen (mg/dL) 60.2 20.1 47.6 8.4–19.6
Aspartate aminotransferase (IU/L) 656 68 205 0–30
Alanine aminotransferase (IU/L) 176 37 66 0–41
Total Bilirubin (direct) (mg/dL) NA 0.9 6.1 (4.1) 0–1.0
Creatinine Kinase (IU/L) 21,272 [1,2] 5180[2] 2624 38–174
Creatinine Kinase MB (IU/L) 750.6 [1,2] 172.2[2] NA 0–24
Albumin (g/L) 16.5 [1] 19.4 [1] NA 32–56
Lactate Dehydrogenase (IU/L) 1770 376 377 98–192
Activated Partial Thromboplastin Time (s) 97.8 [1] 83.1 [2] NA 24–33
Prothrombin Time (s) 25.8 [1] 15.7 [2] NA 10–14
International Normalized Ratio 1.68 [1] 0.94 [2] NA <5
ZIKV PCR Pos. Pos. Pos.
CHIKV IgM/IgG/PCR W. pos./Neg./Neg. Neg./Neg./Neg. Neg./Neg./Neg.
DENV IgM/IgG/PCR Neg./Neg./Neg. Neg./Neg./Neg. Neg./Neg./Neg.
HIV IgM/IgG Neg./Neg. Neg./Neg. Neg./Neg.
Leptospirosis IgM Neg./Neg. Neg./Neg. Neg./Neg.
Zika viral load (copies/mL) >1109 8.4103 1.4103
NA=not available on admission; [1] First result determined on admission to the ICU [2]. Highest level determined on the ICU.
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initially improved circulatory parameters, and because leptospi-
rosis or gram negative septicemia was suspected, empirical
therapy with intravenous amoxicillin/clavulanic acid was started
after blood cultures were drawn. While on this treatment for less
than twelve hours, the patient’s condition worsened and he
developed a cardiorespiratory arrest. After cardiopulmonary
resuscitation, breathing and sinus rhythm were restored, but his
pupils were dilated and not responsive to light. He died shortly
after. Laboratory results revealed marked leukocytosis with
neutrophilia, thrombocytopenia, metabolic acidosis, highly ele-
vated CRP, conjugated hyperbilirubinemia, and raised CK, urea and
creatinine levels (Table 1). Bacterial blood and urine culture and
leptospirosis IgM and HIV serology were negative. Serology and
RT-PCR were negative for dengue and chikungunya, but RT-PCR
was positive for ZIKV. Viral load was 1400 copies/mL.
Discussion
In this paper, we describe three fatal cases of ZIKV infection
presentingwith severe and fatal course of disease. Only three other
cases of lethal ZIKV infection in adults have been described in a
report from Colombia [6]. Strikingly, two patients had a similar
septic presentation and rapid disease progression. Additionally,
mild (e.g., hypertension, diabetes mellitus) and severe (i.e.,
leukemia) co-morbidity was also present in these patients,
indicating that such co-morbidities may predispose to a lethal
outcome. Reports fromGuadeloupe andMartinique and Venezuela
on severe and lethal cases of chikungunya describe septic
presentations in similar age groups with similar co-morbidities
[13,14] Additionally, in all three cases, potential acute myocardial
infarction, evidenced by high CK (in all three) and CK-MB (in case
1 and 2) levels, may have been excacerbated by acute ZIKV
infection, for which these patients may have been prone due to
their pre-existing conditions. However, ECG did not showevidence
of myocardial infarction. Another option could be direct involve-
ment of ZIKV causing acute myocarditis, as has been described in
acute dengue infection [15]. Unfortunately, given the absence of
further evidence for such a relationship and absent possibility for
post-mortem analysis, it remains speculative whether ZIKV
infection has caused an irreversible downward spiral of pre-
existing disease orwas directly responsible for the fatal outcome in
these patients.
An important limitation to completely conﬁrm a causal
connection between ZIKV infection and the lethal outcome in
these patients is the possibility of co-infection. However, we were
unable to identify other common pathogens, present in Suriname,
in these patients. Serum tested weakly positive for chikungunya
IgM in case 1, yet RT-PCR was negative. All patients tested negative
for bacterial infections or HIV. Leptospirosis was assessed with a
quicktest with limited negative predictive value for acute phase
leptospirosis [16]. Further investigation into this would be
warranted, since it was previously shown that leptospirosis can
present as a febrile illness similar to dengue, and can co-exist in
febrile patients with dengue [17,18]. Malaria was not tested, but
there had been no travel to endemic regions in Suriname [19]. It
was recently suggested that prior infectionwith dengue virus may
cause antibody-dependent enhancement (also seen in heterotypic
secondary dengue infection) of ZIKV infection leading to increased
virus replication in the host with potential downstream effects on
virulence [20]. However, serology did not reveal evidence for prior
dengue infection in our patients. With respect to the ZIKV itself,
mutations could have increased its virulence, yet partial sequenc-
ing of ZIKV from case 1 revealed an envelope sequence similar to
former Surinamese cases (Fig. 1C) [3]. Limited availability of
material of these patients made further investigation into co-
infections or ZIKV mutations impossible.
Two patients presented with thrombocytopenia and two with
coagulopathy, all with clinical sequelae of both such as pronounced
bleeding, petechiae and ecchymosis. These host-responses were
observed in earlier conﬁrmed cases from Colombia and Suriname
and may imply hemorrhagic potential of acute ZIKV infection,
reminiscent of dengue hemorrhagic fever (DHF) [6,7]. Generally,
DHF is associated with high viral loads in the host. Indeed, earlier
studies on dengue virus have shown that high viral loads, due to
high replication rates and delayed viral clearance, accompany the
transition from mild dengue fever to severe and potentially lethal
DHF [17]. Likewise, in the case of chikungunya virus infection,
there is evidence for a positive association between high viral load
and severity of disease [21]. It is striking that our ﬁrst patient also
exhibited a very high viral load (Fig. 1B), who also exhibited the
most pronounced clinical hemorrhagic symptoms. Interestingly,
the patient presented with a short history of symptoms and died
very quickly after presentation. It is tempting to speculate that the
high ZIKV viraemia in this patient played a role in his rapid disease
progression. Potential reasons for absence of high viral load in the
other patients may have been different kinetics and later
presentation after onset of symptoms (Fig. 1A).
How Zika virus is directly linked to severe disease remains to
be determined, yet a possibility could be an exaggerated immune
response of the host. Laboratory results show evidence for
activation of acute and innate immune responses (Table 1),
similarly seen in severe, mostly secondary, cases of dengue fever,
and in cases of chikungunya [13,14,22]. Indeed, especially dengue
is known to cause an intravascular ‘cytokine storm’ associated
with increased vascular permeability, which may result in
potentially lethal dengue shock syndrome [23]. At this point,
only one study has reported slight differences in cytokine levels
between acute and reconvalescent phases of ZIKV infection in a
small cohort of patients [24]. It has also been shown that dengue
virus non-structural protein 1 can target endothelial cells directly
during acute phase infection and cause disruption of endothelial
barrier function and vascular leak [88_TD$DIFF] 25]. A similar mechanism
could be involved in ZIKV infection. Of note, we are currently
evaluating host responses in patients with mild and severe
disease. During prospective inclusion of patients for this objective
we continued to observe severe and lethal cases of acute ZIKV
infection with high viral loads in similar patients (unpublished
data).
In conclusion, considering the severity of our cases, we would
like to emphasize the need for clinical awareness and vigilance for
atypical presentations of ZIKV infection. Indeed, our study shows
that acute ZIKV infection, whether accompanied by underlying
prior diseases or co-infection, may lead to rapid disease progres-
sion. Additionally, hemorrhagic potential of the virusmay be, along
with high viraemia, involved in severe and potentially lethal
outcomes.
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